Oroxylin A, but Not Vasopressin, Ameliorates Cardiac Dysfunction of Endotoxemic Rats

The mortality in septic patients with myocardial dysfunction is higher than those without it. Beneficial effects of flavonoid oroxylin A (Oro-A) on endotoxemic hearts were evaluated and compared with that of arginine vasopressin (AVP) which is used to reverse hypotension in septic patients. Endotoxe...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Liu, Chin-Hung, Chen, Mei-Fang, Tseng, Tzu-Ling, Chen, Lih-Geeng, Kuo, Jon-Son, Lee, Tony Jer-Fu
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2012
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3489109/
https://ncbi.nlm.nih.gov/pubmed/23193421
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/408187
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars